Index Performance
+25.30%
Synbio Average
+17.00%
IBB
Overview
Description
Synthetic biology companies identified by AI with human in the loop. Minimum $1b market cap.
- Inception Date01/08/2024
- WeightingCustom
- # of holdings24
What's inside?
Holdings
All holdings as of July 26, 2024
CSV download
| Bristol Myers Squibb Co. (BMY) | 6.61% | $91.77B | 4.66% | 55.54% | 3.46 |
| Pfizer Inc. (PFE) | 6.10% | $171.02B | -18.61% | 70.56% | 3.92 |
| Neurocrine Biosciences, Inc. (NBIX) | 6.00% | $14.70B | 22.57% | 97.52% | 6.87 |
| Johnson & Johnson (JNJ) | 5.94% | $384.20B | -12.12% | 68.99% | 4.27 |
| Vertex Pharmaceuticals, Inc. (VRTX) | 5.81% | $127.03B | 14.21% | 87.25% | 9.80 |
| Charles River Laboratories International, Inc. (CRL) | 5.05% | $11.43B | -1.73% | 31.65% | 4.10 |
| Cerevel Therapeutics Holdings, Inc. (CERE) | 4.91% | $8.09B | N/A | N/A | N/A |
| Catalent, Inc. (CTLT) | 4.76% | $10.58B | 3.57% | 21.32% | 3.64 |
| Teva Pharmaceutical Industries Ltd. (TEVA) | 4.62% | $19.04B | 4.84% | 46.56% | 2.06 |
| BridgeBio Pharma, Inc. (BBIO) | 4.53% | $5.00B | 11,461.88% | 99.10% | 30.87 |
| Certara, Inc. (CERT) | 4.22% | $2.50B | 7.04% | 45.91% | 8.14 |
| Insmed, Inc. (INSM) | 4.02% | $12.01B | 15.77% | 75.21% | 15.22 |
| Beam Therapeutics, Inc. (BEAM) | 3.97% | $2.65B | -69.39% | 26.71% | 4.91 |
| Denali Therapeutics, Inc. (DNLI) | 3.90% | $3.44B | -100.00% | N/A | 7.38 |
| CRISPR Therapeutics AG (CRSP) | 3.77% | $4.89B | -99.50% | -10,177.58% | 13.62 |
| Amicus Therapeutics, Inc. (FOLD) | 3.70% | $3.04B | 27.97% | 85.76% | 8.91 |
| Morphic Holding, Inc. (MORF) | 3.64% | $2.84B | N/A | N/A | N/A |
| Schrödinger, Inc. (SDGR) | 3.28% | $1.42B | -43.51% | 51.61% | 8.71 |
| Prothena Corp. Plc (PRTA) | 3.13% | $1.33B | -97.69% | -1,674.00% | 8.91 |
| Intellia Therapeutics, Inc. (NTLA) | 3.01% | $2.55B | 129.53% | 91.32% | 37.01 |
| Recursion Pharmaceuticals, Inc. (RXRX) | 2.59% | $2.10B | 13.68% | -5.60% | 45.52 |
| Protagonist Therapeutics, Inc. (PTGX) | 2.29% | $2.44B | N/A | 99.68% | 4.82 |
| Twist Bioscience Corp. (TWST) | 2.09% | $3.35B | 25.13% | 41.01% | 6.41 |
| AbCellera Biologics, Inc. (ABCL) | 2.06% | $911.57M | -18.36% | 32.03% | 18.91 |
Market data by FactSet
